TrainerRoad's caffeine tolerance claims need context

What did @trainerroad actually say?

The claim is straightforward: daily caffeine intake does not reduce the performance-enhancing effects of caffeine supplementation before exercise. They cite a 2022 meta-analysis, referencing PMID 35536449, and conclude that athletes can keep drinking coffee leading up to race day and still expect a boost from strategic caffeine use. That's the core message, and it's worth digging into.

The video references Dr. Saunders and a colleague named "Salty" (likely a transcription error for another researcher) analyzing 1,137 participants across 59 studies, looking at power output, endurance, and strength as performance markers. The conclusion they land on is that habitual caffeine consumers experience the same ergogenic response as low-caffeine consumers. No tolerance penalty, essentially.

Does the science back this up?

Yes, with some important nuance. The cited meta-analysis is real. Saunders et al. (2022, Sports Medicine) is a legitimate, peer-reviewed paper that did analyze habitual caffeine intake as a potential modifier of caffeine's ergogenic effects. The headline finding holds: habitual intake did not significantly attenuate performance benefits.

That said, the research picture is not perfectly clean. Earlier work, including a frequently cited study by Gonçalves et al. (2017, Journal of Science and Medicine in Sport), found some signal that habitual caffeine use might reduce the magnitude of benefit, particularly in high consumers. The Saunders 2022 meta-analysis actually addresses this directly and found the effect was not statistically significant at the population level. So @trainerroad is citing the right study and landing on the right conclusion, broadly speaking.

Where it gets complicated is individual variability. Genetics, specifically CYP1A2 polymorphisms, affect how fast people metabolize caffeine, and this can influence both tolerance and acute response. The meta-analysis cannot fully account for this variation.

What did they get wrong (or right)?

They got the main conclusion right. Giving credit where it's due: @trainerroad did not oversimplify this into clickbait. They cited a real study, named the authors, provided a PMID, and communicated the finding accurately. That is more rigorous than most fitness content on Instagram.

What they glossed over is that "same performance-enhancing effects" at a population level does not mean every individual will respond identically. The meta-analysis captures averages. Someone who consumes 600mg of caffeine daily may genuinely have a blunted response, even if that signal disappears in aggregate data. The video also does not mention dose as a variable. How much caffeine you take before performance matters enormously, and habitual intake interacts with acute dose in ways the video never addresses.

The name "Salty" in the transcript is almost certainly a transcription artifact, not an actual researcher's name. Minor point, but worth flagging for accuracy.

What should you actually know?

If you're a recreational cyclist or triathlete drinking two to three cups of coffee per day, the evidence says you are not sabotaging your pre-race caffeine strategy. The Saunders 2022 meta-analysis is the largest and most recent synthesis on this question, and it lands in your favor.

However, a few practical details matter that the video skips. Caffeine dose for ergogenic benefit is typically studied in the range of 3 to 6 mg per kilogram of body weight, taken about 60 minutes before exercise. Timing, dose, and form (anhydrous caffeine versus coffee) all affect outcomes. The meta-analysis does not give you a free pass to ignore those variables just because your habitual intake is not a penalty.

Also worth knowing: caffeine is on the World Anti-Doping Agency (WADA) monitoring list. It was removed from the prohibited list in 2004, but athletes in sanctioned events should confirm current status. Individual responses vary, and if caffeine causes anxiety or disrupts sleep in the days before competition, that tradeoff may cancel out any performance benefit regardless of what the population-level data shows.